Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
A2AR Biomarker for Suspected ACS with Negative Troponin
NCT03218007Completed
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Nov 2017
- Primary completion
- May 2019
- Countries
- 1
01
Overview
Single-blind, single-arm trial in acute coronary syndrome (ACS), sponsored by Assistance Publique-Hôpitaux de Marseille. Primary endpoint: Dosage of adenosine at 12 months. Started Nov 2017; status: completed.
02
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT03218007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03218007.